Glutathione and the Liver: Detox Claims vs Evidence
Of all the things glutathione is sold for, the liver claim is the one with the most truth in it, and that is exactly why it needs the most care. Glutathione is the liver's principal antioxidant. It is consumed when the liver processes alcohol, drugs and toxins. It is the antidote to paracetamol overdose, given in hospital as its precursor. All of that is real, and all of it is a long way from "a glutathione shot detoxes your liver," which is what the marketing turns it into.
The main page covers what glutathione is and the honest state of the evidence. This page is the liver question alone.
What glutathione does in the liver
The liver clears foreign compounds in two phases. In the first, enzymes modify the compound, often producing an intermediate that is more reactive — and more dangerous — than what came in. In the second, that intermediate is bound to a carrier molecule so it becomes water-soluble and can leave in bile or urine. Glutathione is one of the main carriers in that second phase, and the enzymes that attach it are among the liver's most abundant.
Glutathione also neutralizes the free radicals that the first phase generates, which is its antioxidant role, and it is regenerated afterwards by enzymes that depend on the B vitamins and selenium. The liver makes its own, from three amino acids, and it makes a great deal — the highest concentration of any organ.
So the premise is right: the liver runs on glutathione. The question is whether adding more from outside changes anything, and for whom.
Where it is depleted, and where it is not
Glutathione is genuinely depleted in a few well-defined situations: paracetamol overdose, where it is exhausted binding the toxic intermediate and the liver dies without it; chronic heavy alcohol use; advanced liver disease; severe malnutrition; and some inherited enzyme deficiencies. In those, the deficit is measurable and, in the first case, replacing the precursor is life-saving.
It is not meaningfully depleted in a healthy adult who drinks moderately, takes ordinary medications and eats reasonably. The liver's synthesis keeps pace. There is no "toxin build-up" that a glutathione injection clears, because the liver was not short of glutathione and the compounds it processes do not accumulate waiting for a carrier. "Detox" in this sense describes something the liver does continuously and does not need help with.
The fatty liver pilot
The one piece of clinical evidence people cite is a small Japanese pilot study from 2017 in which around thirty adults with non-alcoholic fatty liver disease took oral glutathione for four months. Liver enzyme levels — ALT in particular — fell, and some markers of fat and oxidative stress improved.
It is a real result and a limited one. The study had no placebo group, so the improvement cannot be separated from the effect of enrolling in a liver study and being told to eat better; it was small; it used the oral form, not an injection; and it measured enzymes, not the liver itself. It has not been followed by a controlled trial. It is enough to make glutathione an interesting molecule in fatty liver research and not enough to make it a treatment, and the treatments that do work — weight loss, the GLP-1 medications with their trial evidence, and the one drug approved for MASH — are where a person with fatty liver should look first.
The claims we do not make
We do not describe glutathione as a liver detox, a liver cleanse, a hangover remedy, or a way to undo what alcohol does. We do not prescribe it to treat fatty liver, hepatitis, or any liver disease — those are diagnosed and managed by a hepatologist or primary clinician, and a person with abnormal liver enzymes needs a cause found, not an antioxidant added. And we do not claim that a healthy liver benefits from more glutathione than it already makes, because there is no evidence that it does.
What we do say is on the main page: a plausible, well-tolerated molecule with a thin evidence base for the things people want it for, prescribed with that said out loud.
If your liver is the reason you are here
Get the panel. Liver enzymes are on the baseline panel, and an abnormal result changes the plan entirely — it goes to a workup before any supplement is considered. Fatty liver is common after forty-five and usually silent, and finding it is far more useful than treating it blind. If the enzymes are normal, the honest answer is that glutathione is not doing anything for your liver that it was not already doing for itself.
Frequently asked questions
The liver uses glutathione continuously to process compounds, and makes its own in abundance. A healthy liver is not short of it, and there is no toxin build-up an injection clears. "Detox" describes what the liver already does.
One small open-label pilot from 2017 in which oral glutathione was associated with lower liver enzymes over four months. No placebo, no follow-up trial, and not the injected form.
Chronic heavy drinking does deplete glutathione, but no trial shows that replacing it protects or repairs the liver. Less alcohol does. We do not treat alcohol-related liver disease.
No — get the cause found first. Abnormal enzymes need a workup, not a supplement. We refer.
Weight loss, and the GLP-1 medications with trial evidence for it. Glutathione is not a treatment for fatty liver.
No. We prescribe it for the reasons on the main page, with the caveats there, and not as a liver treatment.
Where this fits in your plan
The Glutathione Injection page covers what we prescribe and why. Liver enzymes are on the baseline panel, and an abnormal result comes before everything else.
We measure first. Then we act.
References
- Honda Y et al. Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study. BMC Gastroenterology 2017;17:96.
- Lu SC. Regulation of glutathione synthesis. Molecular Aspects of Medicine 2009;30:42–59.
- Forman HJ, Zhang H, Rinna A. Glutathione: overview of its protective roles, measurement, and biosynthesis. Molecular Aspects of Medicine 2009;30:1–12.
- Rinella ME et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 2023;77:1797–1835.
- Vairetti M et al. Changes in glutathione content in liver diseases: an update. Antioxidants 2021;10:364.
- Back toGlutathione Injection
- Semaglutide and fatty liverIn August 2025 Wegovy became the first GLP-1 approved for a liver disease. What ESSENCE showed, who qualifies, and why a liver panel is the first step, not the medication.Read
- NAD+ and alcoholNAD+ is sold for hangovers and "alcohol detox" on the strength of real biochemistry and no trials. What alcohol does to NAD+, what the marketing extrapolates from it, and what we will not claim.Read
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. GLP-1 medications are not suitable for everyone. Results may vary.
Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.